AmCad BioMed Goodwill

AmCad BioMed (4188.TWO) currently reports a goodwill of $31M as of June 2026. That compares with $31M in the prior-year period — up 0.0% year over year. Use the charts on this page to explore AmCad BioMed's goodwill history and peer comparisons.

AmCad BioMed's goodwill was unchanged from $31M to $31M — essentially flat versus a year earlier (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AmCad BioMed reported $31M in goodwill as of June 2026. That compares with $31M in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $31M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AmCad BioMed, and consider following 4188.TWO for alerts when major investors trade the stock.